Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Aptose Biosciences Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $6.70M | $6.70M - $6.70M | $0.00 | -$10.50 | 1 |
| Dec 2027 | $5.20M | $5.20M - $5.20M | $0.00 | -$16.20 | 1 |
| Dec 2026 | $38.86M | $38.86M - $38.86M | $0.00 | -$5.65 | 2 |
| Dec 2025 | $512.0K | $511.0K - $513.0K | $0.00 | -$9.20 | 3 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$42.845 | 0 |
| Dec 2023 | $0.00 | $0.00 - $0.00 | $0.00 | -$230.325 | 0 |